Associate Clinical Professor of Medicine, UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Member of the Healthcare Council
George Beatty, MD, MPH, is Associate Clinical Professor of Medicine at the University of California San Francisco (UCSF), and has been on the faculty since 1998. He served as Director of the UCSF's HIV Clinical Trials Unit at San Francisco General Hospital from 2001 to 2007. Dr. Beatty has 13 years of experience in the management of HIV infection and in particular, management of patients with multi-drug resistant HIV and who are co-infected with viral hepatitis. He also serves as a consultant to the California Department of Corrections, and to various antiretroviral treatment programs in developing countries, advising programs on HIV treatment policy and algorithms. Dr. Beatty has served as a principal investigator for a number of clinical trials of novel antiretroviral agents and treatments for Hepatitis C infection for companies such as Merck, Roche, GlaxoSmithKline, Pfizer, Tibotec, Vical, Serono, Boehringer-Ingelheim, Bristol Myers Squibb, Gilead, and Panacos Pharmaceuticals. (This is me - Update Profile)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
George Beatty has not published any GLG News Analyses.
| Study Group Name | No. Members |
|---|---|
| Infectious Diseases Physicians (US) | 885 |
| HIV Specialists (US) | 367 |
| Physicians who Treat HCV (US) | 111 |
| Maraviroc Experts | 41 |
| Prescribers of Combivir : HIV Specialists (US) | 33 |
George Beatty has not participated in any GLG Live Meetings.